Caliber Wealth Management LLC KS Invests $3.78 Million in UnitedHealth Group Incorporated (NYSE:UNH)

Caliber Wealth Management LLC KS bought a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 7,212 shares of the healthcare conglomerate's stock, valued at approximately $3,778,000.

• Healthcare Stocks Hit Valuation Bottom, 3 Names to Rebound

Several other large investors have also recently made changes to their positions in UNH. Financial Management Professionals Inc. raised its stake in UnitedHealth Group by 0.8% in the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock worth $1,165,000 after buying an additional 17 shares in the last quarter. Global Wealth Strategies & Associates raised its stake in UnitedHealth Group by 28.6% in the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock worth $47,000 after buying an additional 20 shares in the last quarter. Kolinsky Wealth Management LLC raised its stake in UnitedHealth Group by 1.0% in the fourth quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock worth $1,080,000 after buying an additional 21 shares in the last quarter. Retirement Planning Group LLC raised its stake in UnitedHealth Group by 5.1% in the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock worth $225,000 after buying an additional 21 shares in the last quarter. Finally, Net Worth Advisory Group raised its stake in UnitedHealth Group by 0.6% in the first quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate's stock worth $1,907,000 after buying an additional 21 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Down 4.8%

UNH stock opened at $278.52 on Friday. The company has a market cap of $252.66 billion, a price-to-earnings ratio of 11.66, a PEG ratio of 1.45 and a beta of 0.45. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The firm has a 50-day moving average of $301.79 and a two-hundred day moving average of $427.21.

UnitedHealth Group Increases Dividend

• Insiders Spent Millions on These 3 Stocks Over the Past 2 Months

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were issued a $2.21 dividend. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 3.17%. UnitedHealth Group's dividend payout ratio is presently 37.02%.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. upped their price target on UnitedHealth Group from $405.00 to $418.00 and gave the stock an "overweight" rating in a research report on Friday, June 20th. Morgan Stanley reduced their price target on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Baird R W downgraded UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, June 11th. Erste Group Bank downgraded UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Finally, Raymond James Financial downgraded UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, UnitedHealth Group has a consensus rating of "Moderate Buy" and a consensus price target of $394.43.

• Why Wall Street Is Betting on These 3 Comeback Stocks

Read Our Latest Stock Analysis on UnitedHealth Group

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,533 shares of the business's stock in a transaction dated Wednesday, May 14th. The stock was acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the acquisition, the director directly owned 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO John F. Rex purchased 17,175 shares of the business's stock in a transaction dated Friday, May 16th. The shares were purchased at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the acquisition, the chief financial officer directly owned 203,796 shares in the company, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 109,408 shares of company stock worth $31,607,768. Insiders own 0.28% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

• Five stocks we like better than UnitedHealth Group
• Low PE Growth Stocks: Unlocking Investment Opportunities
• Congress Is Dumping These 5 Stocks—Should You Follow?
• Find and Profitably Trade Stocks at 52-Week Lows
• GE Vernova's Q2 Electrifies Stock, What's Next For This Top Name?
• What is a penny stock? A comprehensive guide
• From Zero to Hero? Why GoPro's Rally Could Be More Than It Seems

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here